please help, I have done part 1 but got stuck in part 2

PR_13-1A data-1.png OH 1 Search PR 13-1A Statement of Cash Flows-Indirect Method Obj. 2, 3, 4, 5 The comparative balance sheet of Livers Inc. for December 31, 2013 and 2012, is shown as follows: Dec 21, 2013 Dec 31, 2012 $ 150,000 400,000 750,000 100.000 Aut Cash Accounts receivable to Inventories Investments und Equipment Accumulated depreciation equipment Total assets Labtes sodholder Accounts payable merchandise Credito Accrued expenses payable operating perses Dividends payable Common stock, 54 par Pudin capital in excess of por.common stock Retained emings Totatables and stockholders equity $ 155,000 450,000 770.000 o 500.000 1.400,000 600,000 $2.575.00 1,200,000 500 000 $2.100.000 5340.000 45.000 30,000 700,000 200.000 10000 $2,675.000 5390.000 50.000 25,000 Go4.000 175.000 950.000 $2.100.000 Additional data obtained from an examination of the accounts in the ledger for 2013 are as follows: a The investments were sold for $175.000 cash b. Equipment and land were acquired for cash. d. There were no disposals or equipment during the year. d. The common stock was issued for cash e. There was a 5,000 credit to Related Emines for niet income Hi there was a $90,000 debitokeained Pannings for dis didends declared Instructions Prepare a statement of ash flow us the indirect method of presenting cash flows from operating activities A Check Figure: Netcash flow from operating ctivities $190.000 B C D E G 5 Score: 98% 7 Key Code: Key code here 8 Instructions 9 Answers are entered in the calls with gray backgrounds. 10 Calls with non-gray backgrounds are protected and cannot be edited. 11 An asterisk (*) wit appear to the right of an incorrect entry. The optional worksheet wit not be graded 12 but is provided as an aid in determining amounts for the statement 13 14 + Llvers Inc. Statement of Cash Flows For the Year Ended December 31, 2023 $ 500,000 15 16 17 18 19 20 21 22 23 24 25 26 27 28 100,000 (75,000) (50,000) (20,000) 40,000 (5.000) Cash flows from (used for) operating activities: Net Income Adjustments to reconcilo net income to not cash flow from operating activities: Depreciation Gain on sale of investments Changes in current operating assets and liabilities: Increase in accounts receivable Increase in inventories Increase in accounts payablo Decrease in accrued expenses payable Net cash flow from operating activities Cash flows from (used for investing activities Cash received from sale of investments Cash paid for purchase of land Cash paid for purchase of equipment Net cash flow used for investing activities Cash flows from (used for) financing activities: Cash received from sale of common stock Cash paid for dividonds Net cash flow from financing activities 30 31 32 33 $ 495.000 $ 175,000 (500.000) (200,000) (525,000) 35 36 37 38 39 50 51 52 3 $ 125.000 (85,000) 40,000 Not increase (decrease) in cash Cash balance, January 1, 20Y3 Cash balance. December 31, 20Y3 $ 5,000 150,000 $ 165.000 55 18 27 Optional: Pr. 13-1A Ready Credit Balance, Dec 31, 20Y3 155,000 450,000 770,000 Livers Inc. Spreadsheet (Work Sheet) for Statement of Cash Flows For the Year Ended December 31, 2043 Balance, Transactions Dec. 31, 20Y2 Debit Cash 150,000 Accounts receivable (net) 400,000 Inventories 750,000 Investments 100,000 Land Equipment 1.200,000 Accum. depr.-equipment (500,000) Accounts payable (300,000) Accrued expenses payable (50,000) Dividends payable (25,000) Common stock, $4 par (600,000) Paid-in capital in excess of par (175,000) Retained earnings (950,000) Totals Operating activities: Net income Depreciation Gain on sale of investments Increase in accounts receivable Increase in inventories Increase in accounts payable Decrease in accrued expenses payable Investing activities Purchase of equipment Purchase of land Salo of investments Financing activities: Declaration of cash dividends Sale of common stock Increase in dividends payablo Not change in cash Totals 500,000 1,400,000 (600,000) (340,000) (45,000) (30,000) (700.000) (200,000) (1.360,000) PR_13-1A data-1.png OH 1 Search PR 13-1A Statement of Cash Flows-Indirect Method Obj. 2, 3, 4, 5 The comparative balance sheet of Livers Inc. for December 31, 2013 and 2012, is shown as follows: Dec 21, 2013 Dec 31, 2012 $ 150,000 400,000 750,000 100.000 Aut Cash Accounts receivable to Inventories Investments und Equipment Accumulated depreciation equipment Total assets Labtes sodholder Accounts payable merchandise Credito Accrued expenses payable operating perses Dividends payable Common stock, 54 par Pudin capital in excess of por.common stock Retained emings Totatables and stockholders equity $ 155,000 450,000 770.000 o 500.000 1.400,000 600,000 $2.575.00 1,200,000 500 000 $2.100.000 5340.000 45.000 30,000 700,000 200.000 10000 $2,675.000 5390.000 50.000 25,000 Go4.000 175.000 950.000 $2.100.000 Additional data obtained from an examination of the accounts in the ledger for 2013 are as follows: a The investments were sold for $175.000 cash b. Equipment and land were acquired for cash. d. There were no disposals or equipment during the year. d. The common stock was issued for cash e. There was a 5,000 credit to Related Emines for niet income Hi there was a $90,000 debitokeained Pannings for dis didends declared Instructions Prepare a statement of ash flow us the indirect method of presenting cash flows from operating activities A Check Figure: Netcash flow from operating ctivities $190.000 B C D E G 5 Score: 98% 7 Key Code: Key code here 8 Instructions 9 Answers are entered in the calls with gray backgrounds. 10 Calls with non-gray backgrounds are protected and cannot be edited. 11 An asterisk (*) wit appear to the right of an incorrect entry. The optional worksheet wit not be graded 12 but is provided as an aid in determining amounts for the statement 13 14 + Llvers Inc. Statement of Cash Flows For the Year Ended December 31, 2023 $ 500,000 15 16 17 18 19 20 21 22 23 24 25 26 27 28 100,000 (75,000) (50,000) (20,000) 40,000 (5.000) Cash flows from (used for) operating activities: Net Income Adjustments to reconcilo net income to not cash flow from operating activities: Depreciation Gain on sale of investments Changes in current operating assets and liabilities: Increase in accounts receivable Increase in inventories Increase in accounts payablo Decrease in accrued expenses payable Net cash flow from operating activities Cash flows from (used for investing activities Cash received from sale of investments Cash paid for purchase of land Cash paid for purchase of equipment Net cash flow used for investing activities Cash flows from (used for) financing activities: Cash received from sale of common stock Cash paid for dividonds Net cash flow from financing activities 30 31 32 33 $ 495.000 $ 175,000 (500.000) (200,000) (525,000) 35 36 37 38 39 50 51 52 3 $ 125.000 (85,000) 40,000 Not increase (decrease) in cash Cash balance, January 1, 20Y3 Cash balance. December 31, 20Y3 $ 5,000 150,000 $ 165.000 55 18 27 Optional: Pr. 13-1A Ready Credit Balance, Dec 31, 20Y3 155,000 450,000 770,000 Livers Inc. Spreadsheet (Work Sheet) for Statement of Cash Flows For the Year Ended December 31, 2043 Balance, Transactions Dec. 31, 20Y2 Debit Cash 150,000 Accounts receivable (net) 400,000 Inventories 750,000 Investments 100,000 Land Equipment 1.200,000 Accum. depr.-equipment (500,000) Accounts payable (300,000) Accrued expenses payable (50,000) Dividends payable (25,000) Common stock, $4 par (600,000) Paid-in capital in excess of par (175,000) Retained earnings (950,000) Totals Operating activities: Net income Depreciation Gain on sale of investments Increase in accounts receivable Increase in inventories Increase in accounts payable Decrease in accrued expenses payable Investing activities Purchase of equipment Purchase of land Salo of investments Financing activities: Declaration of cash dividends Sale of common stock Increase in dividends payablo Not change in cash Totals 500,000 1,400,000 (600,000) (340,000) (45,000) (30,000) (700.000) (200,000) (1.360,000)